By Josh Beckerman
Shares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units.
The 52-week high of $5.94 took place on Aug. 12.
Each unit consists of a Series H convertible preferred share and a warrant to buy half of a preferred share.
Biolase said May 4 that it planned to offer units. The next day, shares declined 25%, to 20 cents.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
May 24, 2023 12:44 ET (16:44 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.